biomimetics

(redirected from biomimetic)
Also found in: Dictionary, Thesaurus, Medical.

biomimetics

[¦bī·ō·mə¦med·iks]
(biochemistry)
A branch of science in which synthetic systems are developed by using information obtained from biological systems.
Mentioned in ?
References in periodicals archive ?
Grasso's group is one of several involved in a large project designed to build biomimetic soft actuators capable of operating in a cluttered environment, maneuvering over and around objects, and then grabbing an object of interest and manipulating it.
BioMimetic will be mailing a proxy statement/prospectus for its stockholders and each will be filing other documents regarding the proposed transaction with the SEC.
In addition, BioMimetic shareholders could get a further USD6.
Transferring this inspiration to bipolar plates, MFC created Biomimetic plates that streamline the flow of gases through a highly branched flow field, which uses a system of tiny capillaries to deliver gas.
In connection with the proposed transaction, Wright has filed with the SEC a registration statement on Form S-4, which includes a proxy statement/prospectus and other relevant materials in connection with the proposed transaction, and each of Wright and BioMimetic intend to file with the SEC other documents regarding the proposed transaction.
M2 EQUITYBITES-November 19, 2012-Wright Medical to buy BioMimetic Therapeutics for up to USD380m(C)2012 M2 COMMUNICATIONS http://www.
1 February 2011 - US BioMimetic Therapeutics Inc (NASDAQ: BMTI) said yesterday that the US Food and Drug Administration (FDA) has tentatively scheduled an Orthopedic and Rehabilitation Devices Panel meeting on 12 May 2011 to review the company's Premarket Approval (PMA) application for Augment Bone Graft for the treatment of foot and ankle fusions.
In addition to those described below, forward looking statements contained in this presentation and webcast include, without limitation, statements concerning the possibility of FDA approval of Augment Bone Graft, statements regarding market acceptance of, and expected annual market demand for Augment Bone Graft, statements regarding the expected impact of the transaction with BioMimetic on Wright's adjusted EBITDA and other financial results, and statements about the timing and expected benefits of the transaction.
Biotechnology company BioMimetic Therapeutics Inc (NASDAQ:BMTI) has priced its public offering of 5m shares of common stock at USD8.
7 January 2010 - US biotechnology company BioMimetic Therapeutics Inc (NASDAQ: BMTI) said today that it amended and restated its manufacturing and supply agreement with Novartis Vaccines and Diagnostics Inc, a division of Novartis (VTX: NOVN), for the supply of bulk rhPDGF-BB to BioMimetic.
NEW YORK -- Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of BioMimetic Therapeutics Inc.
Biotechnology company BioMimetic Therapeutics Inc (NASDAQ:BMTI) said on Monday that it has commenced a public offering of 5m shares of its common stock.